Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Change in Acquisitions & Divestments (2020)

Historic Change in Acquisitions & Divestments for Bio (TELA) over the last 1 years, with Q2 2020 value amounting to $5.3 million.

  • Bio's Change in Acquisitions & Divestments changed N/A to $5.3 million in Q2 2020 from the same period last year, while for Dec 2020 it was $9.3 million, marking a year-over-year change of. This contributed to the annual value of $9.3 million for FY2020, which is N/A changed from last year.
  • Bio's Change in Acquisitions & Divestments amounted to $5.3 million in Q2 2020.
  • Bio's 5-year Change in Acquisitions & Divestments high stood at $5.3 million for Q2 2020, and its period low was $4.0 million during Q1 2020.